That’s the what I was expecting to hear. Maybe I
Post# of 148292
This has been a concern all along for Dr L perspective, I won’t forget him saying that. I agree, but I just hope that NP isn’t being completely transparent because he can’t tell shareholders everything.
I guess what I’m saying is I have hope that the FDA is working side by side with us and looking at this problem as well and might have some sort of solution that we didn’t think of? No clue just a guess.
I just hope the FDA doesn’t drop the ball, but I guess I won’t be surprised.
We haven’t had any updates on AGC right?